RANCHO SANTA MARGARITA, Calif., Sept. 9, 2002 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announced a second major distribution deal for its novel Histo-RECAF(tm) and Cryo-RECAF(tm) cancer diagnostic kits. BioCurex's kits will be sold throughout Canada through Somagen Diagnostics Inc. (Edmonton, Alberta), the largest and fastest growing privately owned clinical laboratory products distributor in Canada.
Somagen will sell BioCurex's products through a dedicated sales-force of 14 representatives who have been responsible for taking Somagen to the top of the Canadian diagnostic market. The company, which represents many of the top suppliers in their chosen fields, has broad-based coverage throughout all provinces in Canada.
"I am delighted to have Somagen as our distribution partner for Canada. There are very few potential partners with the pedigree and the ability to sell effectively into the niche immunohistology market as Somagen," said Dr. Paul D. Slowey, Chief Executive Officer for BioCurex. "I feel the Histo-RECAF kit fits in exceptionally well with Somagen's current product offering and future sales should add to their current leadership position in the market."
Somagen Diagnostics' President, Kevin Blackburn, added, "We at Somagen are very excited about the opportunity to partner with BioCurex. Innovative products, such as Histo-RECAF(tm), coupled with a leading team of scientists with a proven history in this market make BioCurex an excellent partner for us. We see significant synergies between this new opportunity and the products and services that we now offer in the histology / pathology laboratory."
BioCurex, Inc. is a biotechnology company that is developing products based on patented/proprietary technology in the areas of cancer diagnosis, tumor imaging ad therapeutics. The technology identifies a cancer marker known as RECAF(tm), which is found on malignant cells from a variety of cancer types but is absent in most normal or benign cells. Detailed information about BioCurex may be obtained from their website at http://www.biocurex.com.
Somagen Diagnostics Inc. is a privately owned clinical laboratory products distributor based in Edmonton, Alberta Canada. The company was incorporated in 1988 and has grown to become Canada's largest private distributor growing at an average of over 20% per year over the past 6 years. Somagen specializes in highly technical diagnostic products focused in the Cellular Pathology and Immunology markets, among others. Somagen offers sales, service and technical support in all 10 Canadian provinces and has 43 employees. Further information about Somagen may be obtained from their website at http://www.somagen.com/ or by calling the corporate office at (780) 702-9500.
Note:
Statements in this press release, which are not historical facts, are ``forward-looking statements'' within the meaning given to that term in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results could differ materially from expected results.